We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Probiotics ranked by clinical evidence, with strains, dosing, and the digestive and immune goals they support.
Top picks: Probiotics, Saccharomyces Boulardii, and Akkermansia.
Live microorganisms where strain selection determines outcome — Lactobacillus and Bifidobacterium strains best studied for gut, immune, and mood.
Antibiotic-resistant probiotic yeast ideal for preventing traveler's diarrhea and protecting gut flora during antibiotic therapy.
A next-generation gut bacterium studied mainly for metabolic health. A small proof-of-concept RCT hinted at insulin-sensitivity benefits, but a larger 2025 trial was null overall — improvement appeared only in people who started with low Akkermansia levels. Promising but early, with a thin and inconsistent human evidence base.